Need professional-grade analysis? Visit stockanalysis.com
$48.41B
9.13
28,138
4.20%
Price Chart
Risk-Adjusted Performance
Guangzhou Baiyunshan Pharma (0874) Price Performance
Guangzhou Baiyunshan Pharma (0874) trades on Hong Kong Stock Exchange in HKD. The company is classified in the Healthcare sector under the Medical Distribution industry. The stock currently trades at HKD17.21, down 8.21% from the previous close.
Over the past year, 0874 has traded between a low of HKD15.17 and a high of HKD20.26. The stock has gained 3.6% over this period. It is currently 15.1% below its 52-week high.
Guangzhou Baiyunshan Pharma has a market capitalization of $48.41B, with a price-to-earnings ratio of 9.13 and a dividend yield of 4.20%.
About Guangzhou Baiyunshan Pharma
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited researches, develops, manufactures, and sells Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials. The company operates through Great Southern TCM, Great Commerce, Great Health, and Other segments. It is also involved in the wholesale, retail, sale, import, and export of Western and Chinese medicines, medical instruments, pharmaceutical products, medical apparatus, and healthcare products; research and development, production, and sale of beverages, food, healthcare products, and other products; and production and sale of pre-packaged food, dairy products, etc., as well as offers herbal tea, tablets, capsules, lozenges, tortoise herb jelly, etc. In addition, the company invests in health industry, such as medical services, health management, health preservation and elderly care, etc.; and provides leasing and commercial, health, advertising, loading offloading, and warehouse services. It operates through retail chain pharmacy outlets and retail stores. The company operates in the People's Republic of China and internationally. The company was formerly known as Guangzhou Pharmaceutical Company Limited and changed its name to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited in August 2013. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China.
Company Info
- Sector
- Healthcare
- Industry
- Medical Distribution
- Exchange
- Hong Kong Stock Exchange
- Currency
- HKD
- Country
- Hong Kong
Financial Metrics
- Revenue (TTM)
- $77.54B
- EBITDA
- $4.25B
- Profit Margin
- 3.85%
- EPS (TTM)
- 2.16
- Book Value
- 26.24
Technical Indicators
- 52 Week High
- HK$20.40
- 52 Week Low
- HK$15.01
- 50 Day MA
- HK$18.91
- 200 Day MA
- HK$18.49
- Beta
- 0.29
Valuation
- Trailing P/E
- 9.13
- Forward P/E
- 17.18
- Price/Sales
- 0.62
- Price/Book
- 0.72
- Enterprise Value
- $47.75B